Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247. https://doi.org/10.1016/j.ejca.2008.10.026

Article  CAS  PubMed  Google Scholar 

Zamboni GA, Cappello G, Caruso D et al (2024) ESR Essentials: response assessment criteria in oncologic imaging-practice recommendations by the European Society of Oncologic Imaging. Eur Radiol. https://doi.org/10.1007/s00330-024-11006-w

Gregory J, Dioguardi Burgio M, Corrias G et al (2020) Evaluation of liver tumour response by imaging. JHEP Rep 2:100100. https://doi.org/10.1016/j.jhepr.2020.100100

Article  PubMed  PubMed Central  Google Scholar 

Seymour L, Bogaerts J, Perrone A et al (2017) iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 18:e143–e152. https://doi.org/10.1016/S1470-2045(17)30074-8

Article  PubMed  PubMed Central  Google Scholar 

Ko C-C, Yeh L-R, Kuo Y-T, Chen J-H (2021) Imaging biomarkers for evaluating tumor response: RECIST and beyond. Biomark Res 9:52. https://doi.org/10.1186/s40364-021-00306-8

Article  PubMed  PubMed Central  Google Scholar 

Yoon SH, Kim KW, Goo JM et al (2016) Observer variability in RECIST-based tumour burden measurements: a meta-analysis. Eur J Cancer 53:5–15. https://doi.org/10.1016/j.ejca.2015.10.014

Article  PubMed  Google Scholar 

Kim GY, Jalali A, Gard G et al (2024) Initial assessment of resectability of colorectal cancer liver metastases versus clinical outcome. Clin Colorectal Cancer. https://doi.org/10.1016/j.clcc.2024.10.001

Kuhlmann KF, Tufo A, Kok NF et al (2023) Disappearing colorectal liver metastases in the era of state-of-the-art triple-modality diagnostic imaging. Eur J Surg Oncol 49:1016–1022. https://doi.org/10.1016/j.ejso.2023.01.011

Article  CAS  PubMed  Google Scholar 

Dromain C, Sundin A, Najran P et al (2021) Tumor growth rate to predict the outcome of patients with neuroendocrine tumors: performance and sources of variability. Neuroendocrinology 111:831–839. https://doi.org/10.1159/000510445

Article  CAS  PubMed  Google Scholar 

Wesdorp NJ, Bolhuis K, Roor J et al (2021) Total tumor volume response versus RECIST upon systemic treatment in patients with initially unresectable colorectal liver metastases. HPB (Oxford) 23:S834. https://doi.org/10.1016/j.hpb.2021.08.341

Article  Google Scholar 

Ozaki K, Higuchi S, Kimura H, Gabata T (2022) Liver metastases: correlation between imaging features and pathomolecular environments. Radiographics 42:1994–2013. https://doi.org/10.1148/rg.220056

Article  PubMed  Google Scholar 

Poultsides GA, Bao F, Servais EL et al (2012) Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome. Ann Surg Oncol 19:2797–2804. https://doi.org/10.1245/s10434-012-2335-1

Article  PubMed  Google Scholar 

Chen MYM, Bechtold RE, Savage PD (2002) Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GISTs) treated with Gleevec (Imatinib Mesylate). AJR Am J Roentgenol 179:1059–1062. https://doi.org/10.2214/ajr.179.4.1791059

Article  PubMed  Google Scholar 

Maino C, Vernuccio F, Cannella R et al (2023) Liver metastases: the role of magnetic resonance imaging. World J Gastroenterol 29:5180. https://doi.org/10.3748/wjg.v29.i36.5180

Article  PubMed  PubMed Central  Google Scholar 

Sobeh T, Inbar Y, Apter S et al (2023) Diffusion-weighted MRI for predicting and assessing treatment response of liver metastases from CRC—a systematic review and meta-analysis. Eur J Radiol 163:110810. https://doi.org/10.1016/j.ejrad.2023.110810

Article  PubMed  Google Scholar 

Cheung HMC, Karanicolas PJ, Hsieh E et al (2018) Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy. Eur Radiol 28:3505–3512. https://doi.org/10.1007/s00330-018-5331-4

Article  PubMed  PubMed Central  Google Scholar 

Boonsirikamchai P, Asran MA, Maru DM et al (2011) CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol 197:W1060–W1066. https://doi.org/10.2214/AJR.11.6459

Article  PubMed  Google Scholar 

Chun YS, Vauthey J-N, Boonsirikamchai P et al (2009) Association of computed tomography morphological criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA J Am Med Assoc 302:2338–2344. https://doi.org/10.1001/jama.2009.1755

Article  CAS  Google Scholar 

Wesdorp NJ, Kemna R, Bolhuis K et al (2022) Interobserver variability in CT-based morphologic tumor response assessment of colorectal liver metastases. Radiol Imaging Cancer 4:e210105. https://doi.org/10.1148/rycan.210105

Article  PubMed  PubMed Central  Google Scholar 

Choi H, Charnsangavej C, Faria SC et al (2007) Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol Off J Am Soc Clin Oncol 25:1753–1759. https://doi.org/10.1200/JCO.2006.07.3049

Article  Google Scholar 

Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH (2013) Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol 201:W15–W28. https://doi.org/10.2214/AJR.12.9498

Article  PubMed  Google Scholar 

Zhou Y, Zhang J, Dan Pu J et al (2019) Tumor calcification as a prognostic factor in cetuximab plus chemotherapy-treated patients with metastatic colorectal cancer. Anticancer Drugs 30:195. https://doi.org/10.1097/CAD.0000000000000726

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goyer P, Benoist S, Julié C et al (2012) Complete calcification of colorectal liver metastases on imaging after chemotherapy does not indicate sterilization of disease. J Visc Surg 149:e271–e274. https://doi.org/10.1016/j.jviscsurg.2012.03.002

Article  CAS  PubMed  Google Scholar 

Ma Y, Wang Q, Dong Q et al (2019) How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy. Am J Cancer Res 9:1546–1553

CAS  PubMed  PubMed Central  Google Scholar 

Paulatto L, Burgio MD, Sartoris R et al (2020) Colorectal liver metastases: radiopathological correlation. Insights Imaging 11:99. https://doi.org/10.1186/s13244-020-00904-4

Article  PubMed  PubMed Central  Google Scholar 

Kim H, Roh TH, Lee JS et al (2023) Metastatic papillary renal cell carcinoma with portal vein tumor thrombosis confirmed on blind liver biopsy. J Liver Cancer 24:113–117. https://doi.org/10.17998/jlc.2023.11.05

Article  PubMed  PubMed Central  Google Scholar 

Tomimaru Y, Sasaki Y, Yamada T et al (2010) Liver metastasis originating from colorectal cancer with macroscopic portal vein tumor thrombosis: a case report and review of the literature. J Med Case Reports 4:382. https://doi.org/10.1186/1752-1947-4-382

Article  PubMed Central  Google Scholar 

Vernuccio F, Dioguardi Burgio M, Barbiera F et al (2019) CT and MR imaging of chemotherapy-induced hepatopathy. Abdom Radiol (NY) 44:3312–3324. https://doi.org/10.1007/s00261-019-02193-y

Article  PubMed  Google Scholar 

Gopalakrishnan D, Shajihan A, Purysko AS, Abraham J (2021) Pseudocirrhosis in breast cancer—experience from an academic cancer center. Front Oncol 11:679163. https://doi.org/10.3389/fonc.2021.679163

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ichikawa S, Goshima S (2024) Key CT and MRI findings of drug-associated hepatobiliary and pancreatic disorders. Jpn J Radiol 42:235–245. https://doi.org/10.1007/s11604-023-01505-z

Article  PubMed  Google Scholar